Crossmark

Development and alpha-testing of a patient decision aid for patients with chronic myeloid leukemia regarding dose reduction

Published Online: 2024-12-20

Authors

Lokhorst, D. N.

Djodikromo, M. F.

Hermens, R. P. M. G.

Blijlevens, N. M. A.

Bekker, C. L.
Funding

Funding for this research was provided by:

ZonMw (10140021910501, 10140021910501, 10140021910501, 10140021910501, 10140021910501)
License Information

Text and Data Mining valid from 2024-12-20

Version of Record valid from 2024-12-20
More Information

Article History

Received: 13 June 2024

Accepted: 5 December 2024

First Online: 20 December 2024

Declarations

:

: Ethical review was waived by the Medical Ethical Review Committee of the Radboud university medical center (protocol No.2021–7342). Written informed consent was obtained from participants.

: Not applicable.

: The authors declare no competing interests.

Document is current